Related by context. All words. (Click for frequent words.) 72 PDE4 inhibitor 70 oral prodrug 69 tezampanel 69 Pimavanserin 69 cannabinor 69 ASONEP 68 PS# [001] 68 XmAb# 68 Bicifadine 68 Archexin 68 RhuDex 68 reslizumab 67 Guanilib 67 Menerba 67 mertansine 67 Factor VIIa 67 Sym# 67 otelixizumab 67 PRX # 67 selective androgen receptor modulator 67 Traficet EN 67 SinuNase 67 atacicept 67 Panzem R 67 Serdaxin 67 DDP# 67 NP2 Enkephalin 66 ATL# [001] 66 Aflibercept 66 ProSavin 66 CRx 66 Relivar 66 Nanobody 66 EndoTAG TM -1 66 elotuzumab 66 Capesaris 66 ularitide 66 vidofludimus 66 PRT# 66 torezolid phosphate 66 INCB# [001] 66 Ketotransdel 66 GALNS 66 JAK inhibitor 66 PXD# 66 tanespimycin 66 ganetespib 66 Chrysalin 66 Spiegelmer ® 66 CORT # 66 pradefovir 65 IAP inhibitor 65 R#/MEM # 65 Xanafide 65 NGX# 65 PLK1 SNALP 65 OncoVEX 65 liposomal formulation 65 custirsen 65 Apoptone 65 RhuDex ® 65 bremelanotide 65 targeted radiotherapeutic 65 Tyrima 65 DCVax R 65 zileuton 65 incyclinide 65 CCX# 65 HuMax CD# 65 Vilazodone 65 eniluracil 65 SRT# [003] 65 iSONEP 65 bicifadine 65 IMA# 65 MAP# 65 CDP# 65 ICA # 65 Azedra TM 65 Iloperidone 65 TELINTRA 65 Synavive ™ 65 obatoclax 65 Zoraxel 65 KRN# 65 Gabapentin GR 65 TKM ApoB 65 orally bioavailable 65 Mipomersen 65 TriRima 65 phase 2a 65 nalbuphine ER 65 Onconase 65 Phenoptin 65 Cardio Vascu Grow 65 PSN# [001] 65 methylnaltrexone 65 baminercept 65 RSD# 64 faropenem 64 MAGE A3 ASCI 64 Rezular 64 favorable pharmacokinetic profile 64 adipiplon 64 CA4P 64 ulimorelin 64 Panzem R NCD 64 dexpramipexole 64 JZP 64 Phase 2a trial 64 MYDICAR ® 64 Desmoteplase 64 Phase Ib clinical trials 64 long acting muscarinic 64 ARIKACE ™ 64 proteasome inhibitor 64 Anavex #-# 64 TG# [003] 64 SNT MC# 64 PEG SN# 64 SinuNase ™ 64 preclinical efficacy 64 MAXY G# 64 HuMax EGFr 64 AAG geldanamycin analog 64 GLP toxicology studies 64 JAK1 64 synthetic retinoid 64 Triolex 64 Tezampanel 64 SinuNase TM 64 Zenvia ™ 64 phase IIb 64 octreotide implant 64 Virulizin ® 64 Corlux 64 CoFactor 64 PSN# [002] 64 Panzem 64 OMS#HP 64 Ostarine 64 Phase Ib study 64 tezampanel NGX# 64 ocrelizumab 64 Lu AA# 64 BEMA TM Fentanyl 64 enzastaurin 64 vosaroxin 64 DCCR 64 Cetrorelix 64 CCR2 64 non nucleoside HCV 64 TPI ASM8 64 PNP inhibitor 64 investigational humanized monoclonal antibody 64 dacetuzumab 64 DOS# 64 Symadex 64 AzaSite Plus 64 CCR9 antagonist 64 pomalidomide 64 TOCOSOL Paclitaxel 64 phase IIa clinical 64 6R BH4 64 mGluR2 NAM 64 EndoTAG TM 64 volociximab 64 JAK inhibitors 64 Neurodex 64 Dalbavancin 64 CIMZIA TM 63 Pruvel 63 Anidulafungin 63 ONCONASE R 63 pertuzumab 63 ELND# 63 preclinically 63 ospemifene 63 HuLuc# 63 Saforis 63 Angiocept 63 tiapamil 63 cancer immunotherapies 63 tranilast 63 BRAF inhibitor 63 anidulafungin 63 EndoTAGTM 1 63 Golimumab 63 Phase 1a clinical 63 Lixivaptan 63 VitiGam 63 EP #R 63 HCD# [002] 63 OXi# 63 AQ4N 63 PEG Interferon lambda 63 Ocrelizumab 63 JAK3 inhibitor 63 immunotherapeutic vaccine 63 Phase IIb clinical trials 63 dexanabinol 63 Serdaxin ® 63 BAY #-# 63 epothilone 63 PHX# 63 PD LID 63 budiodarone 63 SAR# [002] 63 Oral NKTR 63 Zelrix 63 Androxal TM 63 Bezielle 63 HSP# inhibitor 63 YONDELIS 63 KNS # 63 alvespimycin 63 PREOS 63 ATL# [002] 63 dextromethorphan quinidine 63 OncoVEX GM CSF 63 TRV# [001] 63 phase IIb clinical 63 budesonide foam 63 Prestara 63 IMC #B 63 Laquinimod 63 BZL# 63 orally administered inhibitor 63 daclizumab 63 Carfilzomib 63 iniparib 63 Valortim 63 Solulin 63 histone deacetylase HDAC inhibitor 63 PEG PAL 63 Azedra 63 novel histone deacetylase 63 LymphoStat B TM 63 Personalized Immunotherapy 63 RhuDex TM 63 beta 1a 63 GLPG# 63 Allovectin 7 63 rNAPc2 63 riociguat 63 HQK 63 ruxolitinib 63 Avicena 63 oxymorphone ER 63 BAL# [002] 63 VQD 63 SARMs 63 PSMA ADC 63 sargramostim 63 ibudilast 63 midstage trials 63 Phase IIa trial 63 celgosivir 63 metaglidasen 63 PORxin TM 62 ocular formulation 62 teriflunomide 62 Syncria 62 AZD# 62 Unit Dose Budesonide 62 alagebrium 62 multi kinase inhibitor 62 HspE7 62 Asentar 62 Nanobody ® 62 DETERx ™ 62 Relovair 62 intranasal formulation 62 Phase 2b clinical trials 62 Plicera 62 OMNARIS 62 valopicitabine NM# 62 GFT# 62 fostamatinib disodium 62 regorafenib 62 HGS# 62 rhIGF-I/rhIGFBP-3 62 diabetic neuropathic pain 62 Phase IIa trials 62 Phase 2a clinical trials 62 Amigal 62 rBChE 62 Arcalyst 62 Maxy G# 62 lurasidone 62 urocortin 2 62 Troxatyl 62 PRTX 62 Hyphanox 62 forodesine 62 virus HCV protease inhibitor 62 FBPase 62 ELADUR 62 Preclinical studies suggest 62 Zalbin 62 MEK inhibitor 62 TELCYTA 62 alvimopan 62 Sulonex 62 Aurexis 62 diarrhea predominant irritable 62 VA# [002] 62 Avanafil 62 BiTE 62 octreotide acetate 62 AEGR 62 Epothilones 62 XP# XP# 62 apremilast 62 efficacy tolerability 62 Talabostat 62 DexaSite 62 CBLC# 62 pharmacodynamic profile 62 NXL# 62 lintuzumab 62 LY# [002] 62 SLx 62 Inhalation Solution 62 interferon gamma 1b 62 LibiGel ® 62 PREOS R 62 INS# [001] 62 PEGylated Fab fragment 62 LEX System 62 therapeutic peptide 62 Phase #b/#a clinical 62 Atu# 62 Pradefovir 62 DermaVir Patch 62 ENMD # 62 PF # [002] 62 ALN PCS 62 Phase Ib 62 confirmatory Phase III 62 HDL Mimetic Peptide 62 IRX 2 62 ALVESCO HFA 62 mecamylamine 62 selective modulator 62 EVIZON ™ 62 Enkephalin 62 mapatumumab 62 MNTX 62 DPX Survivac 62 class mGluR5 inhibitor 62 Radezolid 62 Phase IIa clinical trials 62 VEGF Trap 62 Nuvion 62 Xinlay 62 cangrelor 62 TAFA# 62 EGS# 62 novel topoisomerase 62 nitric oxide donating 62 Surfaxin LS 62 Octreolin 62 Squalamine 62 OvaRex R 62 Excellagen 62 NV1FGF 62 tecarfarin 62 Vidaza azacitidine 62 Alzhemed TM 62 PCK# 62 zileuton CR 62 partial agonist 62 BrachySil 62 aldehyde dehydrogenase ALDH2 deficiency 62 Phase #b/#a 62 CGEN # 62 selective estrogen receptor modulator 62 ATL/TV# 62 Mpex 62 NTDDS 62 OvaRex ® MAb 62 Abiraterone acetate 62 huC# DM4 62 RhuDex R 62 immune modulating 62 Phase IIb trials 62 Prednisporin 62 immunomodulatory 62 Itopride 62 Auxilium transmucosal film 62 belinostat 62 HCV protease 62 Targretin 61 CRMD# 61 hypoxia activated prodrug 61 PrevOnco 61 LEP ETU 61 Memryte 61 glucagon receptor 61 fostamatinib 61 atrasentan 61 erlotinib Tarceva 61 Dual Opioid 61 Dacogen injection 61 R roscovitine 61 aleglitazar 61 Dyloject TM 61 Levadex 61 BNC# 61 Orapred ODT 61 NVA# 61 Amplimexon 61 CD# antibody [001] 61 indibulin 61 SomatoKine 61 phase IIa 61 ganaxolone 61 EndoTAG 61 Tesetaxel 61 telaprevir VX 61 Clonicel 61 IMC A# 61 CRD5 61 Vandetanib 61 RGB # 61 pharmacodynamic properties 61 TREANDA 61 CEQ# 61 pan HDAC inhibitor 61 talactoferrin 61 sorafenib Nexavar 61 Dextofisopam 61 Rebif ® 61 Addrenex 61 Firazyr 61 S/GSK# 61 cathepsin K inhibitor 61 Alocrest 61 neuroprotective properties 61 Targeted Chemotherapy 61 lomitapide 61 vascular disrupting agents 61 Cethrin 61 selective adenosine 61 ALN TTR# 61 MDV# 61 ALVESCO R 61 Hsp# inhibitor 61 midstage clinical 61 Aurora kinase 61 JAK3 61 ESBA# 61 eltrombopag 61 cilengitide 61 Proquin XR 61 Diamyd ® 61 leading oral taxane 61 linaclotide 61 GRNVAC1 61 INCB# [002] 61 Isis antisense 61 nitric oxide donating prostaglandin 61 nicotinic alpha 7 61 SYN# 61 Frova ® 61 HuMax CD4 61 QLT# 61 TBC# 61 PEGylated 61 Darusentan 61 MYDICAR 61 MGd 61 URG# 61 Nebido 61 Phase 2b clinical 61 MEK inhibitors 61 THR beta agonist 61 NPC 1C 61 Cleviprex TM clevidipine 61 R#/MEM 61 Bevasiranib 61 MTP inhibitor 61 allosteric modulator 61 tafamidis 61 overactive bladder AA# 61 TRIOLEX 61 TLR agonists 61 Alnylam #x# 61 investigational compounds 61 EVIZON 61 phase Ib 61 PrevOnco ™ 61 Tasimelteon 61 glucokinase activator 61 multitargeted 61 Ketotransdel TM 61 Atrasentan 61 REG1 61 Vernakalant 61 AcelRx 61 novel VDA molecule 61 Factor Xa inhibitor 61 small molecule tyrosine 61 ANG# 61 HCV protease inhibitor 61 IAP inhibitors 61 sodium glucose cotransporter 61 Hsp# inhibition 61 Exelixis compounds 61 5 HT3 receptor 61 TACI Ig 61 BCX# 61 LEVADEX TM 61 Fibrillex TM 61 CTAP# Capsules 61 ALGRX 61 acetonide FA 61 PDE7 inhibitors 61 JAK2 inhibitors 61 DAVANAT 61 preclinical studies 61 FOLOTYN ® 61 TLK# 61 vascular disrupting agent 61 siRNA therapeutic 61 ApoB SNALP 61 GRN# 61 Ixabepilone 61 A3 adenosine receptor 61 OncoGel 61 EnzymeRx 61 Aurora kinase inhibitor 61 Phase III confirmatory 61 Phenserine 61 oral rivaroxaban 61 CB1 antagonists 61 Daclizumab 61 AeroLEF TM 61 thymalfasin 61 anti angiogenic agent 61 CR# vcMMAE 61 Rasagiline 61 teduglutide 61 Muraglitazar 61 T Pred 61 subcutaneously administered 61 #ME# 61 Phase 2a Clinical Trial 61 Stedivaze 61 investigational monoclonal antibody 61 novel anticancer 61 Tarmogen 61 GSK# [002] 61 cariprazine 61 oral antiviral 61 5 HT6 receptor 61 AKT inhibitor 61 CG# [003] 61 FM VP4 61 AVP #D# 61 epothilones 61 PI3K/Akt pathway inhibitor 61 tubulin inhibitor 61 Milnacipran 61 Bendavia 61 entinostat 61 LCP AtorFen 61 PDE# inhibitors 61 midstage studies 61 Zybrestat 61 Zerenex 61 CB2 selective receptor agonist 61 novel peptide 61 phase IIb trial 61 GAMMAGARD 61 EVIZON TM 61 brivaracetam 61 oral salmon calcitonin 61 Simulect 61 topical ophthalmic 61 successfully commercialize Iluvien 61 Ophena TM 61 Protexia ® 61 OHR/AVR# 61 Argatroban 61 anti amnesic 61 Lacosamide 61 docetaxel Taxotere R 61 BGC# 61 HCV protease inhibitors 61 OMNARIS Nasal Spray 61 NeuroSTAT ® 61 pegylated 61 rEV# 61 Iluvien ® 61 ixabepilone 61 pseudobulbar affect PBA 61 rHuPH# 61 CYT# QbG# 61 Ramoplanin 61 orBec 61 CYT# potent vascular disrupting 61 Naproxcinod 61 TRX1 61 Preclinical studies 61 liposomal doxorubicin 61 Aplidin 60 visilizumab 60 aurora kinase 60 Fortical R 60 oral ridaforolimus 60 SILENOR 60 Oglemilast 60 Altastaph 60 subcutaneous formulation 60 Zemiva TM 60 OMNARIS HFA 60 BEMA Buprenorphine 60 miconazole Lauriad ® 60 Phase #b/#a trial 60 GV# [001] 60 antisense drug 60 phase IIb study 60 VALSTAR 60 Aptivus ® 60 generation antisense 60 milnacipran 60 defensin mimetic antibiotic 60 romidepsin novel 60 LT NS# 60 Civacir 60 ASA# 60 polymerase inhibitor 60 MKC# MKC# PP 60 omecamtiv mecarbil 60 TRO# 60 teplizumab 60 opioid induced bowel dysfunction 60 Sphingomab 60 DXL# 60 systemic RNAi therapeutic 60 Hedgehog antagonist 60 Curaxin 60 LEVADEX 60 Granulocyte Colony Stimulating Factor 60 Solzira 60 vapreotide acetate 60 Leukine ® 60 ISIS # 60 JAK2 inhibitor 60 siRNA therapeutics 60 GLYX 60 proteasome inhibitors 60 almorexant 60 PEGylated interferon 60 desvenlafaxine 60 BioVant 60 humanized anti 60 droxidopa 60 immunotherapeutic 60 Phase IIB 60 investigational compound 60 ANYARA 60 aplindore 60 Nasulin 60 GMX# 60 Captisol enabled 60 dopamine receptor agonist 60 ThGRF 60 liprotamase 60 Emezine 60 ELACYT 60 MGCD# [001] 60 Dapagliflozin 60 VAPRISOL 60 Lodotra 60 rhMBL 60 exon skipping 60 Homspera 60 LY# [003] 60 Vfend 60 OX1 60 Intuniv 60 SAR# [004] 60 Ereska 60 HGS ETR2 60 Pafuramidine 60 LymphoStat B belimumab 60 lasofoxifene 60 renin inhibitor 60 Zolinza 60 Micromet BiTE 60 ACUROX ® 60 ZOLINZA 60 DACH platinum 60 AEG# 60 axitinib 60 BiTE antibody 60 HGS ETR1 60 GSK# [001] 60 ceftaroline 60 NUVIGIL 60 CRLX# 60 Fentanyl TAIFUN R 60 Quinamed 60 Nanobodies 60 Valdoxan 60 generation FBPase inhibitor 60 resolvins 60 paclitaxel Taxol 60 adenosine injection 60 cetuximab Erbitux R 60 CINQUIL 60 Fibrin Pad 60 tramiprosate 60 trodusquemine 60 XL# XL# XL# XL# 60 SNRI 60 ATPace TM 60 HCV polymerase inhibitors 60 immunostimulatory 60 Aryplase 60 midstage clinical trial 60 tasimelteon 60 Polymer Microspheres 60 Treanda 60 efficacy endpoint 60 Alequel ™ 60 Octreotide 60 Thiovir 60 cediranib 60 ecabet sodium 60 Fodosine 60 Resten NG 60 Perforomist ™ Inhalation Solution 60 nucleoside analog 60 MyVax 60 oral taxane 60 CD# CEA 60 MoxDuo 60 mGluR5 negative 60 XP #L 60 safinamide 60 bazedoxifene 60 Aganocide 60 lumiliximab 60 Hsp# inhibitors 60 Anturol TM 60 QVA# 60 Zemplar Capsules 60 Virulizin 60 Locteron ® 60 bardoxolone methyl 60 RezularTM 60 Orazol 60 receptor tyrosine kinase inhibitor 60 renin inhibitors 60 YONDELIS R 60 Cellegesic 60 Androxal ® 60 antiangiogenic 60 daptomycin 60 alemtuzumab Campath 60 Trofex 60 romidepsin 60 therapeutic monoclonal antibodies 60 fosbretabulin 60 Icatibant 60 liposomal 60 bafetinib 60 Pagoclone 60 D aspartate NMDA receptor 60 seliciclib CYC# 60 outlicensing 60 motesanib 60 NexACT ® 60 IPL# 60 Aerosurf 60 lintuzumab SGN 60 selective GR 60 davalintide 60 synthetic siRNA 60 GED aPC 60 NEUGENE antisense 60 Posiphen 60 ILUVIEN ® 60 Vaxfectin 60 Elvitegravir 60 trastuzumab DM1 60 Ceflatonin 60 fluoroquinolone antibiotic 60 opioid induced 60 Glufosfamide 60 bosutinib 60 MoxDuo IR 60 radiation sensitizer 60 Novolimus 60 Solazed TM 60 pitavastatin 60 RAPAFLO 60 CIMZIA ™ 60 lenalidomide dexamethasone 60 tipifarnib 60 deforolimus 60 selective kinase inhibitor 60 targeting CD# 60 Gaboxadol 60 Optiquel ™ 60 sunitinib malate 60 Debio 60 menadione 60 Chemophase 60 generation antisense inhibitor 60 bifeprunox 60 angiogenesis inhibitor 60 preclinical 60 Arikace 60 IIa trial 60 Prosaptide 60 NasalFent 60 TASKi3 60 LEUKINE 60 APOPTONE 60 Indiplon 60 valopicitabine 60 Anticalin ® 60 glufosfamide 60 Zingo TM 60 XL# XL# XL# 60 ALN TTR 60 Perifosine 60 Aliskiren 60 cobiprostone 60 CYCLOSET 60 Shigamabs ® 60 Cethrin R 60 ancrod 60 oral anticancer 60 peptidomimetic 60 EFAPROXYN 60 CCX# B 60 ATHX 60 intravenous acetaminophen 60 thetreatment 60 P#X# antagonist 60 Vitaxin 60 novel prodrug 60 immunomodulating 60 Phase 2b trial 60 velafermin 60 topical antifungal 60 Tolvaptan 60 unoprostone isopropyl 60 Kevetrin 60 iloperidone 60 Fentanyl Taifun 60 Imprime PGG 60 RLY# 60 Interferon alpha 59 Sudhir Agrawal D.Phil 59 EOquin 59 DAVANAT ® 59 posaconazole 59 Crofelemer 59 neuroprotection 59 OMP #M# 59 etanercept Enbrel 59 eprotirome 59 M6G 59 AVE# 59 Safinamide 59 intranasal insulin product 59 antitumoral 59 Epratuzumab 59 ciclesonide 59 TLR8 agonist 59 Telintra 59 Indaflex TM 59 ARX# [001] 59 immune modulatory 59 ONTAK 59 MyVax R 59 PDE4 inhibitors 59 Catena ® 59 intranasal delivery 59 nanoviricide 59 Dendreon Provenge 59 Neuradiab 59 EpiCeram TM 59 IV Busulfex 59 Prodarsan ® 59 Myocet 59 dose escalation Phase 59 Locteron 59 Homspera TM 59 small molecule thrombopoietin 59 Panzem NCD 59 antitumor 59 prodrug 59 Xerese 59 Celgene Revlimid 59 KSP inhibitor 59 GAP #B# 59 chemically modified siRNA 59 balsalazide tablet 59 inhaled antibiotic 59 QNEXA 59 AZILECT R 59 IMiDs R 59 #I TM# 59 levocetirizine 59 dirucotide 59 Linjeta TM 59 isoform selective 59 NEUGENE 59 Excellarate 59 Allovectin 7 R 59 Tarceva TM 59 investigational antiplatelet agent 59 CCR5 antagonist 59 delafloxacin 59 Coreg CR 59 Hedgehog Pathway Inhibitor 59 AMPA kainate 59 HFA MDI 59 PDE# 59 MAXY alpha 59 neratinib 59 Multimeric 59 GRN#L 59 INT# [002] 59 Phase 2a clinical 59 Fidaxomicin 59 adrenergic regulation 59 fipamezole 59 Pacira 59 Leukine 59 SPARLON 59 APEX PD 59 next generation URAT1 59 hepatitis C protease inhibitor 59 Silodosin 59 SYGNIS 59 TMC# [002] 59 Adentri 59 pharmacokinetic PK profile 59 anti CD3 monoclonal 59 antifibrotic 59 signal transduction inhibitor 59 ART# 59 IV APAP 59 Phase Ib clinical 59 TRPV1 agonist 59 Cethromycin 59 pharmacological chaperone 59 tolerability profiles 59 PRX# 59 Phase IIb clinical 59 TNF alpha inhibitor 59 selective A2A adenosine receptor 59 OXIGON TM 59 uric acid lowering 59 ABILIFY ® 59 Maribavir 59 Neo Kidney Augment 59 Phase 1b clinical 59 sodium glucose transporter 59 Removab 59 Frova 59 Flutiform TM 59 DPP4 inhibitor 59 bardoxolone 59 dimebon latrepirdine 59 ACTEMRA TM 59 mGluR2 positive 59 TOCOSOL Camptothecin 59 Davanat 59 crofelemer 59 sitaxsentan 59 Lenocta 59 acyclovir Lauriad R 59 TOLAMBA 59 generation purine nucleoside 59 Cloretazine ® 59 selective S#P# receptor agonist 59 Tarvacin 59 hylan GF 59 FluINsure 59 PROMACTA 59 Sphingomab TM 59 IND enabling 59 formerly LymphoStat B 59 Plenaxis TM 59 Janus Kinase 59 prescribed proton pump 59 receptor inhibitor 59 Pruvel ™ 59 immunomodulator